Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Chan Andrew C. — Corvus Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Chan Andrew C.

Chan Andrew C.

Director at Corvus Pharmaceuticals, Inc. · on record since Apr 27, 2026

Insider trading activity of Chan Andrew C.

Transactions on record: 1; since Apr 27, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 27, 2026

Figures computed from official regulatory filings — methodology.

Companies where Chan Andrew C. has traded

Corvus Pharmaceuticals, Inc.1 tx · Apr 27, 2026

Track record of Chan Andrew C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Chan Andrew C.

Co-insiders of Chan Andrew C.

ADAMS STREET PARTNERS LLCCorvus Pharmaceuticals, Inc.
Arcara JeffreyCorvus Pharmaceuticals, Inc.
Buggy Joseph JCorvus Pharmaceuticals, Inc.
CLARK IAN TCorvus Pharmaceuticals, Inc.
Coloma Jason VCorvus Pharmaceuticals, Inc.
EcoR1 Capital, LLCCorvus Pharmaceuticals, Inc.
Gould Terry PCorvus Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Grais Linda SCorvus Pharmaceuticals, Inc.

Hunt Daniel W.Corvus Pharmaceuticals, Inc.

ISALY SAMUEL DCorvus Pharmaceuticals, Inc.

Jones William BentonCorvus Pharmaceuticals, Inc.

Krognes Steve E.Corvus Pharmaceuticals, Inc.

LEA LEIVCorvus Pharmaceuticals, Inc.

MILLER RICHARD A MDCorvus Pharmaceuticals, Inc.

Mitchell Edith P.Corvus Pharmaceuticals, Inc.

Mobasher MehrdadCorvus Pharmaceuticals, Inc.

Moldt PeterCorvus Pharmaceuticals, Inc.

Moore David ScottCorvus Pharmaceuticals, Inc.

Morrison Scott WCorvus Pharmaceuticals, Inc.

Novo A/SCorvus Pharmaceuticals, Inc.

ORBIMED ADVISORS LLCCorvus Pharmaceuticals, Inc.

OrbiMed Capital GP V LLCCorvus Pharmaceuticals, Inc.

Thompson Peter ACorvus Pharmaceuticals, Inc.

van den Broek RichardCorvus Pharmaceuticals, Inc.

Verner Erik J.Corvus Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Corvus Pharmaceuticals, Inc.	Apr 27, 2026	AwardD	30,000	0.00 USD	$0	SEC